Clinical Trials Directory

Trials / Suspended

SuspendedNCT00345306

Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan

Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan - a Clinical Comparative Study

Status
Suspended
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers

Summary

The transfer of frozen-thawed embryos can be performed in a natural ovulatory cycle or in a hormonally manipulated cycle with a comparable pregnancy rate of 15%-20% per ET. When a hormonally modulated ET cycle is scheduled,an artificial endometrial preparation is carried out using estrogen stimulation followed by a concomitant progesterone treatment. Two progestative drugs are currently used in conventional IVF treatment, Utrogetan and Endometrin. Although Endometrin has been be efficiently used to support the luteal phase after embryo transfer in IVF cycles, currently, there is no study that assess its efficacy for clinical use in frozen-thawed ET cycles. The present study aims to compare the outcome of frozen thawed ET cycles when either Endometrin or Utrogestan are used as the progestative substitution in an artificially prepared endometrium.

Conditions

Interventions

TypeNameDescription
DRUGComparison between two different progesterone administration

Timeline

Start date
2007-03-01
First posted
2006-06-28
Last updated
2008-05-07

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT00345306. Inclusion in this directory is not an endorsement.